Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
Atkins MB, Robertson MJ, Gordon M, Lotze MT, DeCoste M, DuBois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML.
Atkins MB, et al. Among authors: ritz j.
Clin Cancer Res. 1997 Mar;3(3):409-17.
Clin Cancer Res. 1997.
PMID: 9815699
Clinical Trial.